trending Market Intelligence /marketintelligence/en/news-insights/trending/CBqI5p8FaLJTKVtEz82gsw2 content esgSubNav
In This List

WAVE Life Sciences adds board member

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


WAVE Life Sciences adds board member

WAVE Life Sciences Ltd. appointed Adrian Rawcliffe as an independent director, effective Feb. 1.

Rawcliffe, who is CFO of Adaptimmune Therapeutics plc, was also appointed to serve as a member of the WAVE Life Sciences board's audit committee.

Further, Takeshi Wada stepped down from the company's board, effective Jan. 31. He will continue to serve WAVE as a scientific adviser.